✦ LIBER ✦

Early detection of interstitial pneumonia by monitoring KL-6 in a chronic hepatitis C patient undergoing pegylated interferon and ribavirin therapy

✍ Scribed by Yuki Ichikawa-Yamada; Satoru Joshita; Yoshinori Tsukahara; Takefumi Kimura; Susumu Morita; Atsushi Kamijo; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Eiji Tanaka

Book ID: 118088436
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 807 KB
Volume: 41
Category: Article
ISSN: 1386-6346
DOI: 10.1111/j.1872-034x.2011.00837.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Restoration of natural killer cell activ

Restoration of natural killer cell activity by pegylated interferon-alpha/ribavirin therapy in chronic hepatitis C patient

✍ Nakamura, Ikuo; Asano, Takeharu; Asabe, Shinichi; Ando, Mayumi; Sano, Takatomo; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 907 KB

Successful natural interferon-β plus rib

Successful natural interferon-β plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-α treatment due to arrhythmia and interstitial pneumonia

✍ Sato, Akira; Yamauchi, Masahiro; Yamada, Takayuki; Kumano, Reiko; Adachi, Kayo; 📂 Article 📅 2014 🏛 Springer Japan 🌐 English ⚖ 433 KB

576 Early detection of depressive sympto

576 Early detection of depressive symptoms during treatment with pegylated interferon α-2 and ribavirin in euthymic chronic hepatitis C patients

✍ P.E. Golstein; F. Oswalde; J. Mendlewicz; J. Deviere; M. Adler 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 127 KB

A randomized trial of 48 versus 24 weeks

A randomized trial of 48 versus 24 weeks of combination pegylated interferon and ribavirin therapy in genotype 6 chronic hepatitis C

✍ Pham Thi Thu Thuy; Chalermrat Bunchorntavakul; Ho Tan Dat; K. Rajender Reddy 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 852 KB

Early decline of hemoglobin can predict

Early decline of hemoglobin can predict progression of hemolytic anemia during pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C

✍ Naoki Hiramatsu; Nao Kurashige; Tsugiko Oze; Tetsuo Takehara; Shinji Tamura; Aki 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

Is Weight Loss a Surrogate Marker of Res

Is Weight Loss a Surrogate Marker of Response to Pegylated Interferon and Ribavirin Therapy in Patients With Chronic Hepatitis C Infection?

✍ Chua, Deborah L. ;Aden, Brandon ;Jacobson, Ira M. ;Gambarin-Gelwan, Maya 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 299 KB